CatalystMarker
← board

MEHA

distress 10/10 · high distress / dilution risk
$0.00-8%today-100% from 52w high
functionalbrandsinc.comFounded 1949Lake Oswego, ORPackaged Foods
Revenue
pre-revenue
Liquidity
$1M
Runway
0.4 yrs
Shares 1y
+162%

Price & events

-97.8% over 6M
$0.00$0.13$0.26Jan 26Apr 26Jul 26964.4Mfinancing: 8-K material_agreement (2026-07-02)financing: 8-K private_placement (2026-05-22)financing: 8-K material_agreement (2026-05-12)financing: 8-K material_agreement (2026-04-20)financing: 8-K material_agreement (2026-03-13)financing: 8-K material_agreement (2026-02-23)financing: 8-K material_agreement (2026-02-09)
CatalystRating changeDilutionFinancingdashed = today
-8.0%
1D
-2.1%
1W
-29.0%
1M
-96.4%
3M
-97.8%
6M
1Y
2Y
5Y
-99.8%
All

Overview

Market Cap
$196.62K
Enterprise Value
$-741.78K
Volume
150.47K
52 Week Range
$0.00 – $2.75
Total Shares
42.74M
Float Shares
40.90M
Short %
13.17%
% Held by Insiders
7.52%
% Held by Institutions
1.10%
RVOL
0.03x

Pipeline · 0 trials · 0 upcoming

ReadoutPhaseDrugIndicationEnrollStatus
No pipeline trials tracked.

Catalyst news & presentations · 4

Approved drugs (0)

  • none — clinical-stage

Capital structure — dilution & financing

Shares out: 42,743,097 · 2 offerings/1y · 1 PIPEs
  • 2026-07-028-Kmaterial_agreement
  • 2026-05-228-Kprivate_placement
  • 2026-05-128-Kmaterial_agreement
  • 2026-04-208-Kmaterial_agreement
  • 2026-03-138-Kmaterial_agreement
  • 2026-02-238-Kmaterial_agreement
  • 2026-02-098-Kmaterial_agreement
🔒 Positioning — Pro
Short interest / days-to-cover, insider buys & sells.
Upgrade to Pro
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to Pro

Wall St ratings

no consensus
  • no recent rating changes

Competitors

  • none identified

Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.